News Otsuka recruits Medibio to pinpoint mental health biomarkers Medibio's technology will be used to gather mental health biomarkers related to Otsuka's Abilify.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
